Salomon & Ludwin
ADMA icon

Salomon & Ludwin’s ADMA Biologics ADMA Stock Holding History

Salomon & Ludwin’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$27.8K Buy
2,773
+441
+19% +$4.08K ﹤0.01% 752
2026
Q2 		$20.1K Sell
2,332
-736
-24% -$6.71K ﹤0.01% 1139
2026
Q1 		$28.2K Buy
3,068
+1,360
+80% +$21.5K ﹤0.01% 824
2025
Q4 		$30.8K Buy
1,708
+28
+2% +$472 ﹤0.01% 599
2025
Q3 		$24.6K Buy
+1,680
New +$28.8K ﹤0.01% 686

Other funds holding ADMA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Ranger Investment Management
Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Marathon Capital Management
Marathon Capital Management Hunt Valley, Maryland $488M AUM 28.5% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bridge City Capital
Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Salomon & Ludwin's ADMA Position: Q3 2026 in Review

Salomon & Ludwin increased its ADMA Biologics (ADMA) stake by 19% in Q3 2026, buying an estimated $4.08K and bringing the position to 2,773 shares worth $27.8K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Salomon & Ludwin first reported a position in ADMA in Q3 2025 and has held it in 5 quarters since. The position peaked at $30.8K in Q4 2025. 144 funds tracked by Wall St. Rank hold ADMA as of Q3 2026.

  • Salomon & Ludwin held 2,773 shares of ADMA Biologics worth $27.8K as of Q3 2026.
  • Salomon & Ludwin bought 441 ADMA Biologics shares in Q3 2026, an estimated $4.08K.
  • ADMA Biologics made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #752 holding.
  • Salomon & Ludwin first reported a position in ADMA Biologics in Q3 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's ADMA Biologics position peaked at $30.8K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.